Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study

BMC Cancer

Table 1 Clinicopathological parameters for patients before matching

Clinicopathological parameters	Adenocarcinoma	Adenocarcinoma with mucinous component (1–50%)	Mucinous adenocarcinoma (> 50%)	P
Gender				0.501
Female	174	25	18
Male	265	29	21
Age				0.150
< 60 years	13	12	16
≥ 60 years	306	42	23
Smoking				0.238
No	328	44	33
Yes	111	10	6
Alcoholism				0.215
No	332	46	32
Yes	107	8	7
ASA class				0.162
II	354	38	29
III	85	16	10
Hypertension				0.952
No	311	39	27
Yes	128	15	12
Diabetes mellitus				0.691
No	381	46	32
Yes	58	8	7
CAD				0.386
No	398	46	34
Yes	41	8	5
Hepatitis				0.821
No	433	53	38
Yes	6	1	1
CEA				0.114
< 5 ng/ml	302	30	24
≥ 5 ng/ml	137	24	15
CA19–9				0.006
<37 U/ml	393	42	30
≥ 37 U/ml	46	12	9
Albumin				0.006
<40 g/dl	155	30	19
≥ 40 g/dl	284	24	20
HGB				0.007
<110 g/L	90	18	15
≥ 110 g/L	349	36	24
Occult blood				0.011
No	145	27	19
Yes	294	27	20
Operation time				0.738
< 3 h	197	25	20
≥ 3 h	242	29	19
Perioperative blood transfusion				0.851
No	333	41	28
Yes	106	13	11
Tumor location				< 0.001
Right-sided	43	16	13
Left-sided	396	38	26
Defunctioning stoma				0.705
No	434	53	39
Yes	5	1	0
Postoperative complication				0.635
Absent	374	46	31
Present	65	8	8
Differentiation				< 0.001
Well/Moderate	368	37	18
Poor	71	17	21
Signet-ring cell component				0.341
Absent	436	54	38
Present	3	0	1
PNI				0.735
Yes	24	3	1
No	415	51	38
LVI				0.551
Yes	54	8	7
No	385	46	32
T stage				< 0.001
1/2	138	7	3
3/4	301	47	36
N stage				0.240
0	224	30	15
1/2	215	24	24
TNM stage				0.240
I/II	224	30	15
III	215	24	24

ASA American Society of Anesthesiologists, CAD coronary artery disease, CEA carcinoembryonic antigen, CA19–9 carbohydrate antigen 19–9, HGB hemoglobin, TNM tumor-lymph node-metastasis, LVI lymphovascular invasion, PNI perineural invasion

ISSN: 1471-2407